- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Eureka Forbes Limited has announced a board meeting, where it reviewed its consolidated financial results for the third quarter and nine months ended December 31, 2024.
Total revenue for the quarter was ₹60,218 lakh, reflecting a growth of approximately 10% from ₹54,250 lakh in the same period last year. The growth can be attributed to increased demand for health and hygiene products as consumers become more health-conscious post-pandemic, alongside an expansion into new markets.
Net profit for the quarter came in at ₹3,503 lakh, an increase from ₹2,297 lakh year-over-year, yielding an EPS of ₹1.81, which indicates improving profitability driven by better operational efficiency and cost management despite rising material costs.
Operational costs decreased by 10% due to a reduction in the cost of materials consumed and efficient handling of employee expenses. The company's focus on cost control measures has improved its margins during this period.
The balance sheet remains healthy, with a significant cash reserve that positions the company well for future investments and potential acquisitions. The cash flow statement also reflects positive cash generation, reinforcing the company's robust financial health.
Looking ahead, Eureka Forbes appears focused on maintaining its competitive edge through innovation in product development and expansion in both existing and new markets. Based on these indicators, investors may consider a buy stance, given the solid financial performance and favorable market conditions.